100.05
-3.83%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Lotus Eye Hospital and Institute
Its shares trade on NSE under the ticker LOTUSEYE.NS. It has been listed since 11 July 2008. In the fiscal year to 31 March 2026, it reported revenue of ₹537.1m and net income of ₹804,000. At that date it held total assets of ₹826.0m and shareholders' equity of ₹601.4m.
Lotus Eye Hospital & Institute Ltd. engages in the provision of eye care and related services. The company is headquartered in Coimbatore, Tamil Nadu. The company went IPO on 2008-07-11. The firm operates primarily in the field of ophthalmology (Eye) and its related operations. The company resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The firm provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The firm operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 11 Jul 2008
- Website
- lotuseye.org ↗
Leadership
Pay as last reported
- Ms. Kavetha SundaramoorthyChairman of the Board
- Dr. K.S. RamalingamChief Executive Officer, Additional Executive Director, since 2020
- Mr. Ramanujam ReghunathanChief Financial Officer
- Mr. M Achuth MenonCompany Secretary, Compliance Officer
- Ms. Sangeetha SundaramoorthyManaging Director, Executive Director, since 2006
- Mr. Perumalsamy MahendranIndependent Director
- Dr. S. NatesanAdditional Non-Executive Independent Director
- Mr. Karthik VeeramaniAdditional Non-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Lotus Eye Hospital operates seven centers across Tamil Nadu and Kerala regions.
- The firm provides advanced treatments like ReLEx SMILE and Robotic Femto Laser Surgery.
- Specialized services include care for refractive errors, cataracts, and diabetic eye conditions.
Weaknesses
- The company is headquartered in Coimbatore, limiting its immediate geographic presence.
- Operations are primarily focused on ophthalmology rather than broader medical specialties.
- Listing occurred in 2008, which may indicate a mature rather than growth phase.
Opportunities
- Expanding Robotic Femto Laser Cataract Surgery services can attract high-value patients.
- Increasing awareness of computer vision syndrome offers new treatment avenues for urban clients.
- Growing prevalence of diabetic eye care needs supports expansion in retinal disease management.
Threats
- Intense competition exists among other eye care providers in the Health Care sector.
- Economic downturns may reduce patient willingness to pay for elective surgeries like Lasik.
- Regulatory changes in the Indian Health Care system could impact operational costs.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.